http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2087546-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14
filingDate 1991-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_586cbae0ca5a6b268f020b2d6d569563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a5928d80584f71b60b29dcf32a8b115
publicationDate 1992-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2087546-A1
titleOfInvention Psychoactive drug and treatment
abstract The method and composition for treating psychotic disorders with psychoactive drugs which bind at the sigma binding site and act as antagonists to inhibiting psychotic action. The preferred compounds are N-cyclohexyl-N-ethyl benzylamine, N-cyclohexyl-N-ethyl 2-phenylethylamine, and bromhexine.
priorityDate 1990-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413322374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19787002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410459834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426153794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410522465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10331476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452061503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9990930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID941651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3518

Total number of triples: 53.